Skip to main content

Find Clinical Trials

Home
Conditions
DNA Virus Infections

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,945 public trials 501 recruiting studies

Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease

NCT00002145

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more
Locations: East Bay AIDS Ctr Berkeley, California, United States

Los Angeles County - USC Med Ctr Los Angeles, California, United States

UCSD San Diego, California, United States

UCSF - San Francisco Gen Hosp San Francisco, California, United States

View all 15 locations

View Trial Details

Completed

A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

NCT00002034

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations: Univ of Alabama at Birmingham Birmingham, Alabama, United States

Summitt Med Ctr / San Francisco Gen Hosp Oakland, California, United States

Stanford at Kaiser / Kaiser Permanente Med Ctr San Francisco, California, United States

Miami Veterans Administration Med Ctr Miami, Florida, United States

View Trial Details

Completed

Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient

NCT00002025

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations: Roche Global Development - Palo Alto Palo Alto, California, United States

View Trial Details

Completed

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.

NCT00002138

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations: Univ of California at San Francisco Gen Hosp San Francisco, California, United States

View Trial Details

Completed

A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS

NCT00002222

Conditions: AIDS-Related Opportunistic Infections, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations: Cornell AIDS Clinical Trials Unit New York, United States

View Trial Details

Completed

Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study

NCT00002146

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Calcium Metabolism Disorders, +25 more
Locations: Oklahoma City Veterans Administration Med Ctr Oklahoma City, Oklahoma, United States

View Trial Details

Completed

A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

NCT00001999

Conditions: Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations: Georgetown Univ Med Ctr Washington D.C., District of Columbia, United States

View Trial Details

Completed

A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma

NCT00002439

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +19 more
Locations: Not specified

View Trial Details

Terminated

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

NCT03107871

Conditions: CMV, Cmv Congenital, Congenital Cmv, +17 more
Locations: Lucile Packard Children's Hospital Palo Alto, California, United States

Rady Children's Hospital - San Diego San Diego, California, United States

UCSF Benioff Children's Hospital San Francisco, California, United States

Children's Healthcare of Atlanta Atlanta, Georgia, United States

View all 30 locations

View Trial Details

Terminated

NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

NCT05262673

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Shenzhen Geno-Immune Medical Institute Shenzhen, Guangdong, China

View Trial Details